Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
26.88
+0.62 (2.36%)
Nov 14, 2024, 4:00 PM EST - Market closed
Tourmaline Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 689 | 532 | - | - |
| Enterprise Value | 408 | 583 | - | - |
| Last Close Price | 26.88 | 26.18 | - | - |
| PB Ratio | 2.15 | 2.60 | - | - |
| P/TBV Ratio | 2.05 | 2.60 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.07 | -0.66 |
| Quick Ratio | 38.70 | 40.57 | 6.06 | 0.40 |
| Current Ratio | 40.33 | 41.76 | 6.10 | 0.40 |
| Return on Equity (ROE) | -31.82% | -39.66% | -549.77% | - |
| Return on Assets (ROA) | -23.82% | -25.87% | -266.29% | - |
| Return on Capital (ROIC) | -24.50% | -26.60% | -314.87% | - |
| Earnings Yield | -9.27% | -7.91% | - | - |
| FCF Yield | -9.54% | -5.28% | - | - |
| Buyback Yield / Dilution | -16.90% | -441.28% | 91.94% | - |
| Total Shareholder Return | -16.90% | -441.28% | 91.94% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.